MedTech giant Stryker has entered into a definitive agreement to acquire all of the issued and outstanding ordinary shares of … continue reading “Stryker to Acquire Wright Medical”
Stryker
FDA Clears Stryker Cementless Mako Total Knee with Triathlon® Tritanium®
Stryker aims to strengthen its leadership position in robotic technology
2014 Prix Galien Award for Best Medical Technology goes to Stryker for Neuro Clot Remover
Stryker’s clever neuro blood-clot removal device has received the Prix Galien USA 2014 Award for Best Medical Technology.
Stryker Snaps up Star Ankle in Small Bone Innovations Acquisition
Stryker Corporation has signed a definitive agreement to acquire assets of Small Bone Innovations, Inc. in an all cash transaction for up to $375 million.
Stryker Completes Berchtold Acquisition
Back in February 2014 we covered the news that Stryker Corporation was to acquire healthcare infrastructure business, Berchtold Holdings in a deal worth $172 million. Now that deal has gone through.
Stryker’s “Patient Safety” Acquisition a Step Closer
Back in January we covered the news that Stryker was to acquire Patient Safety Technologies, Inc. Now it looks like the deal will go through, as shareholders of Patient Safety have voted in favour.
Stryker Completes Pivot Medical Acquisition
Stryker Corporation tells us it has completed its previously announced all-cash acquisition of Pivot Medical Inc., a move the Kalamazoo device company will hope enhances its position in the orthopaedic sports medicine and arthroscopy specialties.
Stryker Launches TREVO® XP PROVUE Clot Retrieval System
Stryker is trumpeting the global launch of its new Trevo® XP ProVue Retriever, expanding its line of stent-based clot retrieval devices with additional shapes and sizes.
Stryker to Acquire Hip Arthroscopy Company, Pivot Medical
Stryker Corporation is to acquire Pivot Medical, Inc., developer of innovative products for hip arthroscopy in a deal the details … continue reading “Stryker to Acquire Hip Arthroscopy Company, Pivot Medical”
Stryker to Acquire Surgical Infrastructure Company Berchtold
Device household name Stryker spreads its wings far beyond Orthopaedics these days, as evidenced with its newly announced acquisition of German surgical equipment maker Berchtold Holding, AG for an enterprise value of $172 million.
Stryker to Sell Neurologica’s CT Scanner in Defined Specialties
Stryker Corporation and NeuroLogica have entered into an exclusive partnership agreement under which Stryker will promote and sell NeuroLogica’s BodyTom portable full body computed tomography (CT) scanner for the specialties of neurosurgery, spine surgery, orthopaedic surgery, and trauma surgery in conjunction with the Stryker NAV3i™ Surgical Navigation Platform.
Stryker Signals Patient Safety Technologies Acquisition
Stryker Corporation is to acquire Patient Safety Technologies, Inc. for an aggregate purchase price of $120 million. Patient Safety Technologies conducts its business through its wholly owned subsidiary, SurgiCount Medical, Inc. The transaction is expected to close in the first quarter of 2014.
Stryker Snaps Up Mako
Mako Surgical Corp. is one of today’s bigger fish in robotic surgery, although it’s had to overcome some choppy waters to get here. Now Stryker has got its teeth into the Florida based robot-assisted knee joint resurfacing outfit, to the tune of a $1.65Bn takeover.
FDA Class I Recall for Stryker Spine’s OASYS Midline Occiput Plate
Back in May, Stryker issued an Urgent Medical Device Recall requesting medical facilities to examine their inventory of five product … continue reading “FDA Class I Recall for Stryker Spine’s OASYS Midline Occiput Plate”
Stryker Spine’s Venom™ Cannula and Electrode Combination and 11g iVAS® Balloon System Get FDA Nod
The U.S. FDA has cleared Stryker Interventional Spine’s Venom RF Cannula and Venom Electrode, designed to provide an effective and minimally invasive treatment for facet joint pain. Stryker says the 11g iVAS Balloon System addresses the surgical trend of shifting toward less invasive treatment options.
Stryker Takes the Pain, But Underlying Picture Looks Pretty Strong
If it’s true that Stryker has suffered from downward pricing pressure, foreign exchange pressure and absorbed recall costs this quarter, it’s perhaps not surprising they sound a bit pessimistic. But restructuring, acquisitions and positive mix changes suggest it’s not all that bad.